The North America legal cannabis market size reached USD 44.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 354.8 Billion by 2033, exhibiting a growth rate (CAGR) of 24.55% during 2025-2033. The growing use for recreational use, wide availability through various distribution channels, and increasing utilization to treat chronic diseases represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 44.8 Billion |
Market Forecast in 2033 | USD 354.8 Billion |
Market Growth Rate (2025-2033) | 24.55% |
Legal cannabis refers to a drug derived from dried leaves, stems, seeds, and flowers of a plant called Cannabis sativa. It has various components, such as cannabidiol (CBD) and tetrahydrocannabinol (THC). It can be easily smoked, vaped, and ingested while having psychoactive properties that provide relaxing and calming effects in the body. It offers an enhanced sense of hearing, vision, and taste and improves sleeping problems. It prevents relapse into drug and alcohol addiction, treats anxiety disorders, and lowers blood pressure. It assists in relieving chronic pains that are caused by numerous diseases among adults. It aids in chemotherapy-induced nausea and multiple sclerosis spasticity symptoms. Besides this, it increases appetite and reduces the risk of migraine, inflammation, and seizures. As it is also consumed to treat asthma and glaucoma, as an antidepressant and anticonvulsant and anti-spasmodic, the demand for legal cannabis is rising across the North American region.
At present, the increasing consumer preference from conventional treatment to cannabis-based treatments represents one of the key factors impelling the growth of the market in the North American region. Besides this, the growing demand for cannabis to reduce stress, anxiety, and depression among individuals is offering a positive market outlook across the region. In addition to this, several banks are approving loans for marijuana businesses to enhance the production process, which is supporting the growth of the market in the region. Moreover, the increasing utilization of legal cannabis to treat several chronic diseases, such as epileptic seizures, chronic pain, and Alzheimer’s, among individuals is propelling the growth of the market in the North American region. Apart from this, the wide availability of legal cannabis through various distribution channels, such as regulated dispensaries, recreational stores, and stand-alone retailers, is positively influencing the market. Additionally, there is a rise in the demand for cannabis for recreational use among the masses. This, coupled with the increasing utilization of hemp-derived cannabidiol (CBD) in the skincare and the cosmetic industry, is offering lucrative growth opportunities to industry investors in the region. Furthermore, the rising demand for marijuana oils and tinctures for treating vomiting and nausea problems among individuals is strengthening the growth of the market in the North American region.
IMARC Group provides an analysis of the key trends in each sub-segment of the North America legal cannabis market report, along with forecasts at the regional and country level from 2025-2033. Our report has categorized the market based on products derived and distribution channel.
Products Derived Insights:
The report has provided a detailed breakup and analysis of the North America legal cannabis market based on the products derived. This includes marijuana, industrial hemp, and others. According to the report, marijuana represented the largest segment.
Distribution Channel Insights:
A detailed breakup and analysis of the North America legal cannabis market based on the distribution channel has also been provided in the report. This includes regulated dispensary, recreational stores, stand-alone retailers, and others. According to the report, regulated dispensary accounted for the largest market share.
Country Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include United States and Canada. According to the report, United States was the largest market for North America legal cannabis. Some of the factors driving the United States legal cannabis market included favorable government rules and legalization, rising utilization of hemp-based products, increasing adoption of marijuana for medicinal usage, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the North America legal cannabis market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include 22nd Century Group, Inc, Medical Marijuana Inc, Hemp, Inc., Axim Biotechnologies, Inc, Arena Pharmaceuticals, Inc., Canopy Growth Corporation, Aphria Inc., Aurora Cannabis Inc., Abcann Medicinals Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Products Derived, Distribution Channel, Country |
Countries Covered | United States, Canada |
Companies Covered | 22nd Century Group, Inc, Medical Marijuana Inc, Hemp, Inc., Axim Biotechnologies, Inc, Arena Pharmaceuticals, Inc., Canopy Growth Corporation, Aphria Inc., Aurora Cannabis Inc. and Abcann Medicinals Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The North America legal cannabis market was valued at USD 44.8 Billion in 2024.
We expect the North America legal cannabis market to exhibit a CAGR of 24.55% during 2025-2033.
The growing adoption of medical cannabis in combination with other therapies to combat the side-effects and increase the effectiveness of the treatment for various chronical ailments, such as chronic pain, cancer, and social anxiety, is primarily driving the North America legal cannabis market.
The sudden outbreak of the COVID-19 pandemic had led to the rising focus on drug discovery and clinical trials for novel vaccines against the coronavirus infection, resulting in the postponement of numerous R&D activities for cannabis-based drugs across several North America.
Based on the products derived, the North America legal cannabis market has been segregated into marijuana, industrial hemp, and others, where marijuana currently holds the largest market share.
Based on the distribution channel, the North America legal cannabis market can be bifurcated into regulated dispensary, recreational stores, stand-alone retailers, and others. Currently, regulated dispensary exhibits a clear dominance in the market.
On a regional level, the market has been classified into United States and Canada, where United States currently dominates the North America legal cannabis market.
Some of the major players in the North America legal cannabis market include 22nd Century Group, Inc, Medical Marijuana Inc, Hemp, Inc., Axim Biotechnologies, Inc, Arena Pharmaceuticals, Inc., Canopy Growth Corporation, Aphria Inc., Aurora Cannabis Inc., Abcann Medicinals Inc., etc.